- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Novavax Inc+ Add to Watchlist
NVAX:US8.8300 USD 0.2600 3.03%
As of 17:20:00 ET on 03/04/2015.
Company Profile for Novavax Inc (NVAX)
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Key Executives for Novavax Inc (NVAX)
|Stanley C ErckPresident/CEO||Barclay A Phillips "Buck"Senior VP/CFO/Treasurer|
|Russell P Wilson "Rip"Senior VP:Business Development||John J TrizzinoSenior VP:Commercial Operations|
|Timothy J HahnSenior VP:Manufacturing||Cynthia N Oliver "Cindy"Senior VP:Process Dev Ops|
|Gregory M Glenn "Greg"Senior VP:Research & Development||Louis Fries III "Lou"VP/Chief Medical Officer|
|Jill HoytVP:HR & Administration||D Nigel ThomasVP:Clinical Operations|